The reaction of indoline with a substituted benzoyl chloride in the presence of K 2 CO 3 in THF gave compound 4. Compound 4 was subjected to chlorosulphonation to obtain compound 5. Condensation of aromatic amines with compound 5 led to the synthesis of indoline derivatives 6(a-f). Similarly, 5-nitroindoline was treated with a substituted benzoyl chloride to obtain the nitro compound 9, which was reduced using stannous chloride and reacted further with aromatic sulphonyl chloride to obtain the indoline derivatives 11(a-e). These compounds were tested for antibacterial, anti-tuberculosis and antifungal activity. Some of them showed very good activity against some gram-positive and gram negative bacteria, fungal strains and also Mycobacterium tuberculosis. All of the synthesized compounds were subjected to antioxidant activity testing using the in vitro DPPH assay and most of them showed very good activity.
INTRODUCTION
Indoline and other related ring systems possess several interesting biological activities. The indolines are also interesting structural scaffolds and have, for example, been evaluated as 5-HT 2C receptor agonists for the treatment of obesity. 1 Factor Xa (FXa) is well known to play a pivotal role in blood coagulation; hence, an FXa inhibitor is a promising drug candidate for prophylaxis and treatment of thromboembolic diseases. Some indoline derivatives have been found to show very good FXa inhibitory activities. 2 Indoline derivatives have also been found to show an antagonistic effect on progesterone receptors. 3 In addition, indolines have been evaluated for antimicrobial activity. 4 Owing to the biological importance of indolines and in continuation of our work on the synthesis of biologically important heterocyclic compounds, the synthesis of some indolines is reported herein.
In present work, the synthesis of novel indoline derivatives is reported starting with the substituted benzoyl chloride 2, which was prepared by the reaction of 4-(aminosulfonyl)benzoic acid with SOCl 2 and DMF. Treatment of 2 with indoline 3 in the presence of K 2 CO 3 in THF afforded compound 4. Compound 4 was subjected to chlorosulphonation to obtain compound 5, which on reaction with aromatic amines in presence of pyridine and a catalytic amount of DMAP using THF as the solvent yielded the indoline derivatives 6(a-f). The synthetic scheme to 6(a-f) is shown in Scheme 1 and the structural data of 6(a-f) are given in Table I . Scheme 1. Similarly, 5-nitroindoline (8) on treatment with compound 7 gave the nitro derivative 9, which was further reduced by stannous chloride to the amino derivative 10. The amino derivative on treatment with aromatic sulphonyl chlorides gave the indoline derivatives 11(a-e). The synthetic scheme to 11(a-e) is shown in Scheme 2 and the structural data of 11(a-e) are given in Table II. The compounds 6(a-f) and 11(a-e) were characterized by FTIR, 1 H-NMR and mass spectroscopy. The compounds 6(a-f) and 11(a-e) were tested for their antioxidant, antibacterial, antifungal and anti-tuberculosis activities.
Amongst the compounds screened for antioxidant activity, 6a, 6b, 6e, 6f and 11 (a-e) showed very good antioxidant activities, as shown in Table III. All the screened compounds, except 6b, 6c, 11d and 11e, exhibited very good antifungal and antibacterial activities, as shown in Tables IV and V, respectively. Compounds 6a (MIC = 100 μg/ml) and 6f (MIC = 62.5 μg/ml) showed promising anti-tuberculosis activity, as shown in Table VI . 
EXPERIMENTAL
All the recorded melting points were determined in an open capillary and are uncorrected. The IR spectra were recorded on a Perkin-Elmer FTIR spectrophotometer in KBr discs. The 1 H-NMR spectra were recorded on a 400 MHz spectrophotometer in DMSO-d 6 as solvent and TMS as the internal standard. The mass spectra were obtained using a Waters mass spectrometer.
4-(2,3-Dihydro-1H-indol-1-ylcarbonyl)-N-[(1E)-(dimethylamino)methylene]-benzenesulphonamide (4)
Compounds 2 (0.010 mol) and 3 (0.010 mol) were dissolved in THF together with K 2 CO 3 . The reaction mixture was stirred at room temperature for 4 h. The reaction mixture was then poured into water and extracted with EtOAc. The organic layer was separated, dried over Na 2 SO 4 
1-[4-({[(1E)-(Dimethylamino)methylene]amino}sulphonyl)benzoyl]indoline-5-sulphonyl chloride (5)
Compound 4 (0.010 mol) was added in portions to a solution of chlorosulphonic acid (10 ml) at 0 °C and stirred for 30 min. The reaction mixture was cooled to room temperature and stirred for a further 1 h. The reaction mixture was then poured into cold water and the formed solid was separated by filtration. Compound 5 (0.010 mol) and the required amine (0.010 mol) were dissolved in THF, together with DMAP and pyridine (0.030 mol). The reaction mixture was stirred at room temperature for 4 h, after which the reaction mixture was poured into dilute HCl and extracted with EtOAc. The organic layer was washed with water, separated, dried over Na 2 SO 4 and concentrated under vacuum. The so-obtained crude product was crystallized from a mixture of CH 2 Cl 2 and hexane.
[3,5-Dimethoxy-4-(2-phenoxyethoxy)phenyl](5-nitro-2,3-dihydro-1H-indol-1-yl)methanone (9)
Compound 7 (0.010 mol) and 8 (0.010 mol) were dissolved in THF, together with K 2 CO 3 . The reaction mixture was stirred at room temperature for 4 h and then poured into water and extracted with EtOAc. The separated, organic layer was dried over Na 2 SO 4 and concentrated under vacuum. [3,5-dimethoxy-4 
-(2-phenoxyethoxy)phenyl]methanone (10)
To a suspension of the nitro derivative 9 (0.10 mol) in methanol (50 ml) were added 5 equivalents SnCl 2 ·2H 2 O and the reaction mixture was heated at 70 °C for 4 h. Then the mixture was cooled to room temperature, poured into aqueous NH 3 and filtered through celite. The filtrate was extracted with EtOAc. The separated organic layer was dried over Na 2 SO 4 and concentrated under vacuum. The product was recrystallized from ethanol.
Compound Compound 10 (0.010 mol) and the required aromatic sulphonyl chloride (0.010 mol) were dissolved in THF, together with DMAP and pyridine (0.030 mol). The reaction mixture was stirred at room temperature for 4 h, after which it was poured into dilute HCl and extracted with EtOAc. The organic layer was washed with water, separated, dried over Na 2 SO 4 and concentrated under vacuum. The crude product was crystallized from a mixture of CH 2 Cl 2 and hexane mixture.
Anti-oxidant activity
The in vitro antioxidant activity of the test compounds was determined by the DPPH method 5 using L-ascorbic acid (an antioxidant agent) as the positive control. The compounds were tested for antioxidant activity at concentrations of 200, 100 and 50 µg/ml.
Antimicrobial activity
The in vitro antimicrobial activity of the test compounds was assessed against 24 h cultures of several selected bacteria and fungi. The employed gram positive and gram negative bacteria were Escherichia coli, Pseudomonas aeruginosa, Streptococcus pyogenes and Staphylococcus aureus and the used fungi were Candida albicans, Aspergillus niger and Aspergillus clavatus.
The antimicrobial activity of all the compounds was tested using Müller Hinton broth (Hi Media M 391) as the nutrient medium for bacterial and Sabouraud Dextrose broth for fungal growth. The media were prepared using distilled-deionized water and dispensed in 25 ml amounts into 100-mm Petri dishes.The activity was determined by measuring the diameter of inhibition zone in millimetres.
Anti-tuberculosis activity
All the compounds were screened for their in vitro antimycobacterial activity against Mycobacterium tuberculosis by the broth macro dilution method. The activity of the compounds was confirmed by MIC determination against M. tuberculosis. A stock solution of each compound (1 mg/ml) was diluted in sterile distilled water to test the range. Each tube contained 4 ml sterile Middle Brook 7H9 broth containing albumin-dextrose-catalase, Tween 80, glycerol and 4 ml of the compound solution was added to make serial double dilutions. The tubes were incubated at 37 °C for 7 days and then read visually. The MIC was determined as the lowest concentration of the test substance that prevented turbidity. Streptomycin, isoniazid, rifampicin and ethambutol were used as the reference standards.
CONCLUSIONS
In conclusion, a series of novel indoline derivatives were synthesized and subjected to various biological activity tests, viz. antioxidant, antifungal, anti-tu-berculosis and antibacterial activity. Most of the compounds showed very good antioxidant and anti-infective activities, which suggest that the indoline core has a very high therapeutic value and needs to be explored in further studies.
